Go Pro
→ Your book attached (From Profits Run) (Ad)tc pixel Free EOLS Stock Alerts

Evolus (EOLS) Financials

Evolus logo
$5.81 +0.26 (+4.68%)
Closing price 04:00 PM Eastern
Extended Trading
$5.80 0.00 (-0.09%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare
Annual Income Statements for Evolus

Annual Income Statements for Evolus

This table shows Evolus' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 -4.48 -47 -90 -163 -47 -74 -62 -50 -52
Consolidated Net Income / (Loss)		 -4.48 -47 -90 -163 -47 -74 -62 -50 -52
Net Income / (Loss) Continuing Operations		 -4.48 -47 -90 -163 -47 -74 -62 -50 -52
Total Pre-Tax Income 		-12 -47 -105 -163 -47 -74 -62 -50 -51
Total Operating Income		 -12 -46 -99 -153 -44 -65 -49 -34 -33
Total Gross Profit		 0.00 0.00 27 38 56 90 138 182 197
Total Revenue		 0.00 0.00 35 57 100 149 202 266 297
Operating Revenue		 - 0.00 35 57 100 149 202 266 297
Total Cost of Revenue		 0.00 0.00 8.01 18 44 59 65 84 100
Operating Cost of Revenue		 - 0.00 8.01 18 44 59 65 84 100
Total Operating Expenses		 12 46 126 191 101 155 187 217 230
Selling, General & Admin Expense		 4.82 29 114 98 112 142 165 198 221
Research & Development Expense		 6.69 6.49 3.97 1.72 2.06 6.74 15 9.17 9.58
Depreciation Expense		 0.22 0.01 4.13 7.03 5.62 0.77 2.18 2.34 4.35
Restructuring Charge		 - - 0.00 2.96 - - 0.00 0.00 1.44
Other Special Charges / (Income)		 - - 0.00 83 -26 5.76 - 7.18 -6.38
Total Other Income / (Expense), net		 -0.01 -0.66 -6.11 -9.87 -2.36 -8.99 -12 -15 -18
Interest Expense		 0.01 - - 0.00 2.36 9.10 14 19 20
Interest & Investment Income		 0.00 0.20 1.84 0.64 0.00 0.12 0.86 3.26 1.93
Other Income / (Expense), net		 - -0.86 -7.95 -11 0.00 -0.01 0.70 0.13 -0.54
Income Tax Expense		 -7.25 0.07 -15 0.08 0.04 0.10 0.18 0.66 0.68
Basic Earnings per Share		 ($0.27) ($1.92) ($3.19) ($4.83) ($0.94) ($1.33) ($1.08) ($0.81) ($0.80)
Weighted Average Basic Shares Outstanding		 16.53M 24.40M 28.24M 33.74M 49.77M 56.07M 56.92M 62.02M 64.47M
Diluted Earnings per Share		 ($0.27) ($1.92) ($3.19) ($4.83) ($0.94) ($1.33) ($1.08) ($0.81) ($0.80)
Weighted Average Diluted Shares Outstanding		 16.53M 24.40M 28.24M 33.74M 49.77M 56.07M 56.92M 62.02M 64.47M
Weighted Average Basic & Diluted Shares Outstanding		 16.53M 24.40M 28.24M 33.74M 55.69M 56.41M 57.94M 63.59M 65.06M

Quarterly Income Statements for Evolus

This table shows Evolus' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders		 -17 -12 -13 -11 -19 -6.79 -19 -17 -16 0.13 -11
Consolidated Net Income / (Loss)		 -17 -12 -13 -11 -19 -6.79 -19 -17 -16 0.13 -11
Net Income / (Loss) Continuing Operations		 -17 -12 -13 -11 -19 -6.79 -19 -17 -16 0.13 -11
Total Pre-Tax Income 		-17 -12 -13 -11 -19 -6.35 -19 -17 -16 0.52 -10
Total Operating Income		 -13 -8.64 -8.92 -7.70 -15 -2.31 -15 -10 -12 4.22 -6.85
Total Gross Profit		 35 39 41 47 42 50 47 45 46 59 49
Total Revenue		 50 61 59 67 61 79 69 69 69 90 73
Operating Revenue		 50 61 59 67 61 79 69 69 69 90 73
Total Cost of Revenue		 15 22 19 20 19 29 22 24 23 31 24
Operating Cost of Revenue		 15 22 19 20 19 29 22 24 23 31 24
Total Operating Expenses		 48 47 49 55 58 53 62 56 57 55 56
Selling, General & Admin Expense		 43 43 45 50 53 50 57 57 53 55 52
Research & Development Expense		 1.59 6.81 2.08 2.35 2.31 2.43 2.21 1.84 2.05 3.48 2.24
Depreciation Expense		 1.31 -1.58 0.65 0.66 0.32 -1.58 0.82 0.93 1.14 1.45 1.54
Other Operating Expenses / (Income)		 - - - 1.61 - - 2.15 -3.91 -0.11 - -0.01
Total Other Income / (Expense), net		 -3.46 -3.09 -4.14 -3.61 -3.56 -4.04 -3.65 -6.88 -4.07 -3.71 -3.57
Interest Expense		 3.79 4.08 4.70 4.70 4.76 4.57 4.42 7.21 4.09 3.98 3.98
Interest & Investment Income		 0.31 0.29 0.52 1.03 0.93 0.79 0.71 0.48 0.48 0.26 0.29
Other Income / (Expense), net		 0.02 0.69 0.05 0.06 0.27 -0.25 0.06 -0.15 -0.46 0.01 0.12
Income Tax Expense		 0.02 0.11 0.05 0.04 0.13 0.44 0.07 0.05 0.17 0.39 0.26
Basic Earnings per Share		 ($0.30) ($0.20) ($0.22) ($0.18) ($0.30) ($0.11) ($0.30) ($0.27) ($0.24) $0.01 ($0.16)
Weighted Average Basic Shares Outstanding		 57.02M 56.92M 58.80M 62.72M 63.15M 62.02M 63.70M 64.54M 64.73M 64.47M 65.19M
Diluted Earnings per Share		 ($0.30) ($0.20) ($0.22) ($0.18) ($0.30) ($0.11) ($0.30) ($0.27) ($0.24) $0.01 ($0.16)
Weighted Average Diluted Shares Outstanding		 57.02M 56.92M 58.80M 62.72M 63.15M 62.02M 63.70M 64.54M 64.73M 64.47M 65.19M
Weighted Average Basic & Diluted Shares Outstanding		 57.15M 57.94M 62.61M 63.09M 63.32M 63.59M 64.48M 64.69M 64.82M 65.06M 65.85M

Annual Cash Flow Statements for Evolus

This table details how cash moves in and out of Evolus' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 -0.19 93 17 -7.33 44 -92 8.92 24 -33
Net Cash From Operating Activities		 -13 -26 -93 -58 -33 -85 -34 -18 -42
Net Cash From Continuing Operating Activities		 -13 -26 -93 -58 -33 -85 -34 -18 -42
Net Income / (Loss) Continuing Operations		 -4.48 -47 -90 -163 -47 -74 -62 -50 -52
Consolidated Net Income / (Loss)		 -4.48 -47 -90 -163 -47 -74 -62 -50 -52
Depreciation Expense		 0.22 0.01 4.13 7.03 5.62 3.72 5.13 5.30 7.51
Amortization Expense		 - 0.86 1.99 2.92 1.91 1.86 1.85 1.87 2.53
Non-Cash Adjustments To Reconcile Net Income		 -0.41 6.97 9.91 97 -3.87 -2.57 17 25 28
Changes in Operating Assets and Liabilities, net		 -8.55 13 -19 -1.38 9.76 -14 3.37 0.52 -29
Net Cash From Investing Activities		 0.00 -0.01 -23 12 4.03 -2.94 -1.63 -4.82 -8.45
Net Cash From Continuing Investing Activities		 0.00 -0.01 -23 12 4.03 -2.94 -1.63 -4.82 -8.45
Purchase of Property, Plant & Equipment		 0.00 -0.01 -4.57 -3.14 -0.97 -2.94 -1.63 -4.82 -8.45
Net Cash From Financing Activities		 13 119 134 38 73 -4.15 45 47 17
Net Cash From Continuing Financing Activities		 13 119 134 38 73 -4.15 45 47 17
Repayment of Debt		 0.00 -5.00 -3.25 -0.52 -100 -0.50 -0.05 0.00 -2.61
Repurchase of Common Equity		 -1.29 -1.30 -0.20 0.00 -0.21 0.00 0.00 -0.25 0.00
Issuance of Debt		 - 0.00 74 40 72 0.00 50 0.00 25
Issuance of Common Equity		 0.00 124 73 0.00 104 0.00 0.23 56 1.16
Other Financing Activities, net		 14 1.13 -10 -1.13 -3.10 -3.65 -5.54 -8.43 -6.22
Effect of Exchange Rate Changes		 - - - - 0.00 -0.34 -0.09 -0.48 0.25
Cash Interest Paid		 - 0.00 5.17 7.24 0.14 8.00 13 18 15
Cash Income Taxes Paid		 - - 0.00 0.07 0.01 0.08 0.12 0.24 1.22

Quarterly Cash Flow Statements for Evolus

This table details how cash moves in and out of Evolus' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents		 -3.02 24 34 -3.29 -8.64 1.92 -19 -6.16 -18 10 -4.03
Net Cash From Operating Activities		 -0.92 0.81 -11 -6.47 -5.72 4.81 -16 -25 -15 13 -9.95
Net Cash From Continuing Operating Activities		 -0.92 0.81 -11 -6.47 -5.72 4.81 -16 -25 -15 13 -9.95
Net Income / (Loss) Continuing Operations		 -17 -12 -13 -11 -19 -6.79 -19 -17 -16 0.13 -11
Consolidated Net Income / (Loss)		 -17 -12 -13 -11 -19 -6.79 -19 -17 -16 0.13 -11
Depreciation Expense		 1.31 1.37 1.41 1.43 1.09 1.37 1.56 1.74 1.95 2.25 2.35
Amortization Expense		 0.43 0.42 0.43 0.44 0.47 0.54 0.56 0.62 0.67 0.68 0.70
Non-Cash Adjustments To Reconcile Net Income		 5.61 8.91 5.27 6.37 6.11 6.96 7.13 5.53 7.60 7.93 5.67
Changes in Operating Assets and Liabilities, net		 8.65 1.94 -4.61 -3.35 5.78 2.73 -5.99 -16 -9.15 1.83 -8.00
Net Cash From Investing Activities		 -0.54 -0.36 -0.80 -1.25 -1.41 -1.36 -1.86 -2.27 -2.16 -2.17 -1.69
Net Cash From Continuing Investing Activities		 -0.54 -0.36 -0.80 -1.25 -1.41 -1.36 -1.86 -2.27 -2.16 -2.17 -1.69
Purchase of Property, Plant & Equipment		 -0.54 -0.36 -0.80 -1.25 -1.41 -1.36 -1.86 -2.27 -2.16 -2.17 -1.69
Net Cash From Financing Activities		 -1.42 24 46 4.48 -1.42 -1.31 -1.63 21 -1.77 0.08 7.62
Net Cash From Continuing Financing Activities		 -1.42 24 46 4.48 -1.42 -1.31 -1.63 21 -1.77 0.08 7.62
Repayment of Debt		 - -0.01 - - - - 0.00 - - - -0.48
Issuance of Debt		 - 25 - - - - 0.00 - - - 10
Issuance of Common Equity		 0.06 -0.20 47 6.51 0.59 -3.38 0.74 0.32 0.02 0.08 0.00
Other Financing Activities, net		 -1.48 -1.28 -1.83 -1.78 -2.01 2.06 -2.37 -4.66 -1.79 2.61 -1.90
Effect of Exchange Rate Changes		 -0.14 0.18 -0.13 -0.04 -0.09 -0.22 0.07 0.24 0.38 -0.44 -0.01
Cash Interest Paid		 3.52 3.80 4.42 4.41 4.47 4.23 4.06 3.73 3.56 3.44 3.25
Cash Income Taxes Paid		 0.04 0.02 0.03 0.14 0.03 0.04 0.05 0.27 0.16 0.74 0.03

Annual Balance Sheets for Evolus

This table presents Evolus' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets		 152 172 240 209 257 178 189 233 226
Total Current Assets		 73 94 152 128 179 101 112 151 143
Cash & Equivalents		 0.00 93 110 103 146 54 63 87 54
Accounts Receivable		 73 0.00 11 9.68 15 22 31 48 55
Inventories, net		 - 0.00 6.41 3.35 1.76 19 11 12 27
Prepaid Expenses		 0.19 1.18 5.33 4.83 5.08 3.90 5.70 3.35 3.76
Other Current Assets		 - - - 2.19 11 1.68 2.36 1.20 3.67
Plant, Property, & Equipment, net		 0.00 0.00 0.90 1.30 1.37 2.62 2.09 3.22 5.37
Total Noncurrent Assets		 79 78 87 80 77 75 74 78 78
Goodwill		 21 21 21 21 21 21 21 21 21
Intangible Assets		 56 56 60 55 51 49 47 49 48
Other Noncurrent Operating Assets		 2.13 0.22 6.50 3.65 5.48 4.76 6.17 8.04 8.33
Total Liabilities & Shareholders' Equity		 152 172 240 209 257 178 189 233 226
Total Liabilities		 228 87 161 282 176 159 210 227 249
Total Current Liabilities		 213 5.28 24 180 58 47 48 63 75
Accounts Payable		 73 1.56 5.80 9.62 6.09 8.94 4.27 9.24 23
Accrued Expenses		 0.98 3.72 14 9.10 30 25 34 41 36
Other Current Liabilities		 - 0.00 4.68 68 22 13 10 13 16
Total Noncurrent Liabilities		 15 82 137 102 118 113 161 164 174
Long-Term Debt		 0.00 17 91 41 71 72 120 122 146
Noncurrent Deferred & Payable Income Tax Liabilities		 15 15 0.00 0.03 0.04 0.02 0.03 0.01 0.03
Other Noncurrent Operating Liabilities		 0.00 50 45 41 42 41 41 43 28
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 -76 84 79 -73 82 18 -21 5.52 -23
Total Preferred & Common Equity		 -76 84 79 -73 82 18 -21 5.52 -23
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 -76 84 79 -73 82 18 -21 5.52 -23
Common Stock		 0.00 207 293 303 505 516 539 616 638
Retained Earnings		 -76 -123 -213 -376 -423 -497 -559 -609 -661
Accumulated Other Comprehensive Income / (Loss)		 - 0.00 0.01 - 0.00 -0.34 -0.43 -0.91 -0.16

Quarterly Balance Sheets for Evolus

This table presents Evolus' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 9/30/2022 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets		 193 160 169 168 226 234 230 213 229 219 221
Total Current Assets		 116 84 96 92 150 158 150 132 145 135 139
Cash & Equivalents		 66 31 42 39 97 94 85 68 62 44 50
Accounts Receivable		 21 23 29 30 34 43 45 47 48 50 52
Inventories, net		 22 23 20 18 12 13 15 10 26 33 25
Prepaid Expenses		 3.66 4.16 4.30 3.66 5.68 5.51 3.40 3.45 4.79 4.60 4.62
Other Current Assets		 4.23 1.59 1.60 1.57 1.84 2.43 2.39 2.89 4.27 3.46 7.50
Plant, Property, & Equipment, net		 1.88 2.60 2.35 2.13 2.09 2.28 2.31 3.25 3.65 5.13 5.34
Total Noncurrent Assets		 75 74 70 74 74 73 77 78 80 79 76
Goodwill		 21 21 21 21 21 21 21 21 21 21 21
Intangible Assets		 49 48 47 47 47 46 47 49 49 49 47
Other Noncurrent Operating Assets		 4.58 4.42 1.75 6.13 6.02 5.87 9.14 7.82 9.63 9.05 8.44
Total Liabilities & Shareholders' Equity		 193 160 169 168 226 234 230 213 229 219 221
Total Liabilities		 163 153 176 187 208 214 224 220 247 248 249
Total Current Liabilities		 51 41 41 49 47 54 61 56 64 67 68
Accounts Payable		 8.56 10 7.84 12 11 10 14 16 23 23 20
Accrued Expenses		 30 22 24 27 25 33 35 27 28 30 32
Other Current Liabilities		 13 8.38 9.33 10 11 11 12 13 12 13 17
Total Noncurrent Liabilities		 112 113 135 139 161 160 163 164 184 181 181
Long-Term Debt		 72 72 95 95 121 121 121 122 145 146 156
Noncurrent Deferred & Payable Income Tax Liabilities		 0.03 0.02 0.02 0.02 0.03 0.03 0.03 0.00 0.02 0.00 0.02
Other Noncurrent Operating Liabilities		 40 41 40 44 40 39 42 42 38 35 25
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 29 6.95 -6.96 -19 18 19 5.89 -6.60 -19 -29 -29
Total Preferred & Common Equity		 29 6.95 -6.96 -19 18 19 5.89 -6.60 -19 -29 -29
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 29 6.95 -6.96 -19 18 19 5.89 -6.60 -19 -29 -29
Common Stock		 514 519 524 528 591 603 609 623 627 633 643
Retained Earnings		 -484 -512 -530 -547 -572 -583 -603 -628 -645 -661 -672
Accumulated Other Comprehensive Income / (Loss)		 -0.37 -0.42 -0.47 -0.61 -0.56 -0.60 -0.69 -0.84 -0.60 -0.14 -0.28

Annual Metrics And Ratios for Evolus

This table displays calculated financial ratios and metrics derived from Evolus' official financial filings.

Metric 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding		 0.00 27,274,991.00 27,425,230.00 33,749,228.00 55,576,988.00 - - - 64,819,784.00
DEI Adjusted Shares Outstanding		 0.00 27,274,991.00 27,425,230.00 33,749,228.00 55,576,988.00 - - - 64,819,784.00
DEI Earnings Per Adjusted Shares Outstanding		 0.00 -1.72 -3.28 -4.83 -0.84 - - - -0.80
Growth Metrics		 - - - - - - - - -
Revenue Growth		 0.00% 0.00% 0.00% 61.89% 76.29% 49.10% 35.98% 31.76% 11.61%
EBITDA Growth		 0.00% -300.88% -118.45% -52.44% 75.99% -62.04% 30.46% 34.74% 14.56%
EBIT Growth		 0.00% -300.86% -127.42% -53.01% 72.85% -47.14% 25.72% 29.37% 3.16%
NOPAT Growth		 0.00% -293.50% -114.44% -54.70% 70.99% -47.12% 24.64% 30.11% 5.08%
Net Income Growth		 0.00% -946.14% -92.11% -81.06% 71.28% -58.97% 17.10% 18.26% -2.42%
EPS Growth		 0.00% -611.11% -66.15% -51.41% 80.54% -41.49% 18.80% 25.00% 1.23%
Operating Cash Flow Growth		 0.00% -94.12% -263.83% 38.03% 42.31% -154.32% 59.95% 47.07% -134.82%
Free Cash Flow Firm Growth		 0.00% 0.00% -550.04% 80.95% -333.75% 10.82% 53.76% 21.55% -90.08%
Invested Capital Growth		 0.00% -87.13% 405.87% -213.27% 114.69% 432.83% 1.03% 8.81% 72.58%
Revenue Q/Q Growth		 0.00% 0.00% 125.64% 2.04% 16.45% 6.44% 9.39% 7.23% 3.97%
EBITDA Q/Q Growth		 0.00% -26.44% -0.35% -163.23% 71.28% 11.22% 6.51% 16.85% 25.23%
EBIT Q/Q Growth		 0.00% -28.81% -2.29% -141.49% 67.64% 10.27% 5.11% 13.55% 16.99%
NOPAT Q/Q Growth		 0.00% -26.44% -0.04% -165.81% 66.96% 10.16% 3.91% 15.52% 16.67%
Net Income Q/Q Growth		 0.00% -56.34% -2.35% -143.93% 66.40% 6.31% 2.12% 9.09% 11.82%
EPS Q/Q Growth		 0.00% -60.00% 0.31% -141.50% 75.07% 13.07% 3.57% 10.00% 13.04%
Operating Cash Flow Q/Q Growth		 0.00% -75.07% -4.38% 19.09% -25.47% 0.32% 21.99% 18.16% 15.95%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% -5.93% 69.74% -84.83% 1.78% 7.21% 18.50% 11.75%
Invested Capital Q/Q Growth		 0.00% 23.33% 21.37% -180.38% -28.42% 3.10% -0.56% -4.72% -5.90%
Profitability Metrics		 - - - - - - - - -
Gross Margin		 0.00% 0.00% 77.05% 67.64% 56.32% 60.41% 68.08% 68.46% 66.33%
EBITDA Margin		 0.00% 0.00% -288.55% -271.71% -37.00% -40.21% -20.56% -10.18% -7.80%
Operating Margin		 0.00% 0.00% -283.31% -270.73% -44.55% -43.96% -24.36% -12.92% -10.99%
EBIT Margin		 0.00% 0.00% -306.08% -289.30% -44.55% -43.97% -24.02% -12.88% -11.17%
Profit (Net Income) Margin		 0.00% 0.00% -257.79% -288.31% -46.96% -50.07% -30.52% -18.94% -17.38%
Tax Burden Percent		 38.19% 100.14% 85.70% 100.05% 100.09% 100.13% 100.29% 101.33% 101.33%
Interest Burden Percent		 100.04% 99.57% 98.28% 99.61% 105.32% 113.74% 126.73% 145.13% 153.50%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 0.00% 0.00% -281.37% 0.00% 0.00% -211.24% -94.05% -62.64% -41.86%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% -245.12% 0.00% 0.00% -110.74% -166.18% -119.84% -87.24%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 171.46% 0.00% 0.00% 62.97% 5,727.38% 727.50% 629.22%
Return on Equity (ROE)		 5.93% -1,060.22% -109.90% -5,016.56% -1,049.79% -148.27% 5,633.33% 664.86% 587.36%
Cash Return on Invested Capital (CROIC)		 0.00% 63.75% -415.35% 0.00% -1,234.84% -348.03% -95.07% -71.08% -95.11%
Operating Return on Assets (OROA)		 0.00% 0.00% -51.86% -72.78% -19.04% -30.01% -26.45% -16.27% -14.48%
Return on Assets (ROA)		 0.00% 0.00% -43.68% -72.53% -20.07% -34.18% -33.62% -23.92% -22.53%
Return on Common Equity (ROCE)		 5.93% -1,060.22% -109.90% -5,016.56% -1,049.79% -148.27% 5,633.33% 664.86% 587.36%
Return on Equity Simple (ROE_SIMPLE)		 5.93% -55.54% -113.31% 223.43% -57.17% -402.25% 298.15% -913.08% 0.00%
Net Operating Profit after Tax (NOPAT)		 -8.21 -32 -69 -107 -31 -46 -34 -24 -23
NOPAT Margin		 0.00% 0.00% -198.32% -189.51% -31.19% -30.77% -17.05% -9.05% -7.69%
Net Nonoperating Expense Percent (NNEP)		 -2.69% 46.67% -36.25% -934.67% -64.67% -100.50% 72.13% 57.20% 45.38%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - -50.60% -34.58% -18.96% -18.59%
Cost of Revenue to Revenue		 0.00% 0.00% 22.95% 32.36% 43.68% 39.59% 31.92% 31.54% 33.67%
SG&A Expenses to Revenue		 0.00% 0.00% 325.25% 173.66% 112.44% 95.44% 81.62% 74.37% 74.29%
R&D to Revenue		 0.00% 0.00% 11.38% 3.05% 2.07% 4.54% 7.63% 3.44% 3.22%
Operating Expenses to Revenue		 0.00% 0.00% 360.37% 338.36% 100.87% 104.37% 92.44% 81.39% 77.32%
Earnings before Interest and Taxes (EBIT)		 -12 -47 -107 -164 -44 -65 -49 -34 -33
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -12 -46 -101 -154 -37 -60 -42 -27 -23
Valuation Ratios		 - - - - - - - - -
Price to Book Value (P/BV)		 0.00 3.85 4.20 0.00 4.42 22.83 0.00 126.60 0.00
Price to Tangible Book Value (P/TBV)		 0.00 45.71 0.00 0.00 36.03 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)		 0.00 0.00 9.56 2.01 3.63 2.84 2.98 2.63 1.45
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 3.15 30.56 7.19 0.00 41.91 12.08 17.90 18.31 7.57
Enterprise Value to Revenue (EV/Rev)		 0.00 0.00 8.46 2.47 2.88 2.96 3.26 2.76 1.76
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 10.93 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - -
Debt to Equity		 -1.84 0.20 1.15 -1.84 0.87 3.89 -5.82 22.00 -6.32
Long-Term Debt to Equity		 0.00 0.20 1.15 -0.56 0.87 3.89 -5.82 22.00 -6.32
Financial Leverage		 -1.84 7.06 -0.70 -1.84 -5.45 -0.57 -34.46 -6.07 -7.21
Leverage Ratio		 -2.02 36.66 2.52 69.17 52.32 4.34 -167.57 -27.80 -26.07
Compound Leverage Factor		 -2.02 36.50 2.47 68.90 55.10 4.93 -212.36 -40.34 -40.02
Debt to Total Capital		 219.64% 16.69% 53.51% 219.60% 46.52% 79.53% 120.76% 95.65% 118.79%
Short-Term Debt to Total Capital		 219.64% 0.00% 0.00% 153.20% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 16.69% 53.51% 66.40% 46.52% 79.53% 120.76% 95.65% 118.79%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 -119.64% 83.31% 46.49% -119.60% 53.48% 20.47% -20.76% 4.35% -18.79%
Debt to EBITDA		 -12.05 -0.37 -0.91 -0.87 -1.93 -1.20 -2.90 -4.48 -6.31
Net Debt to EBITDA		 -12.05 1.65 0.38 -0.17 2.03 -0.30 -1.38 -1.27 -3.98
Long-Term Debt to EBITDA		 0.00 -0.37 -0.91 -0.26 -1.93 -1.20 -2.90 -4.48 -6.31
Debt to NOPAT		 -16.90 -0.52 -1.32 -1.25 -2.29 -1.57 -3.49 -5.04 -6.39
Net Debt to NOPAT		 -16.90 2.36 0.55 -0.25 2.41 -0.39 -1.67 -1.43 -4.04
Long-Term Debt to NOPAT		 0.00 -0.52 -1.32 -0.38 -2.29 -1.57 -3.49 -5.04 -6.39
Altman Z-Score		 -1.89 0.94 -0.68 -4.89 -0.68 -2.33 -1.79 -0.71 -1.87
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - -
Current Ratio		 0.34 17.88 6.23 0.71 3.10 2.17 2.33 2.40 1.90
Quick Ratio		 0.34 17.66 5.75 0.65 2.79 1.64 1.93 2.14 1.44
Cash Flow Metrics		 - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 0.00 23 -102 -19 -84 -75 -35 -27 -52
Operating Cash Flow to CapEx		 0.00% -285,188.89% -2,044.73% -1,844.20% -3,442.06% -2,889.15% -2,090.23% -373.19% -500.06%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 -35.74 -8.28 -2.52 -1.46 -2.64
Operating Cash Flow to Interest Expense		 -2,644.40 0.00 0.00 0.00 -14.12 -9.33 -2.46 -0.96 -2.15
Operating Cash Flow Less CapEx to Interest Expense		 -2,644.40 0.00 0.00 0.00 -14.53 -9.66 -2.58 -1.22 -2.58
Efficiency Ratios		 - - - - - - - - -
Asset Turnover		 0.00 0.00 0.17 0.25 0.43 0.68 1.10 1.26 1.30
Accounts Receivable Turnover		 0.00 0.00 0.00 5.56 8.19 8.01 7.63 6.81 5.81
Inventory Turnover		 0.00 0.00 0.00 3.75 17.02 5.71 4.32 7.25 5.12
Fixed Asset Turnover		 0.00 0.00 0.00 51.42 74.72 74.55 85.94 100.31 69.17
Accounts Payable Turnover		 0.00 0.00 2.18 2.37 5.54 7.83 9.77 12.43 6.14
Days Sales Outstanding (DSO)		 0.00 0.00 0.00 65.66 44.56 45.56 47.84 53.60 62.87
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 97.35 21.45 63.93 84.44 50.33 71.35
Days Payable Outstanding (DPO)		 0.00 0.00 167.47 153.70 65.84 46.60 37.36 29.36 59.45
Cash Conversion Cycle (CCC)		 0.00 0.00 -167.47 9.31 0.17 62.90 94.93 74.58 74.77
Capital & Investment Metrics		 - - - - - - - - -
Invested Capital		 63 8.13 41 -47 6.84 36 37 40 69
Invested Capital Turnover		 0.00 0.00 1.42 -20.73 -5.02 6.86 5.51 6.92 5.44
Increase / (Decrease) in Invested Capital		 0.00 -55 33 -88 53 30 0.38 3.24 29
Enterprise Value (EV)		 199 248 295 140 287 440 659 734 523
Market Capitalization		 60 325 334 113 362 422 602 699 431
Book Value per Share		 ($4.57) $3.09 $2.90 ($2.16) $1.47 $0.33 ($0.36) $0.09 ($0.36)
Tangible Book Value per Share		 ($9.25) $0.26 ($0.05) ($4.43) $0.18 ($0.91) ($1.56) ($1.02) ($1.42)
Total Capital		 63 101 171 61 153 90 100 127 123
Total Debt		 139 17 91 134 71 72 120 122 146
Total Long-Term Debt		 0.00 17 91 41 71 72 120 122 146
Net Debt		 139 -76 -38 26 -75 18 58 35 92
Capital Expenditures (CapEx)		 0.00 0.01 4.57 3.14 0.97 2.94 1.63 4.82 8.45
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -1.24 -4.10 -2.05 -67 -25 0.37 1.29 1.43 14
Debt-free Net Working Capital (DFNWC)		 -1.24 89 128 41 121 54 64 88 68
Net Working Capital (NWC)		 -140 89 128 -53 121 54 64 88 68
Net Nonoperating Expense (NNE)		 -3.73 15 21 56 16 29 27 26 29
Net Nonoperating Obligations (NNO)		 139 -76 -38 26 -75 18 58 35 92
Total Depreciation and Amortization (D&A)		 0.22 0.87 6.12 9.95 7.53 5.58 6.98 7.17 10
Debt-free, Cash-free Net Working Capital to Revenue		 0.00% 0.00% -5.86% -118.05% -25.20% 0.25% 0.64% 0.54% 4.64%
Debt-free Net Working Capital to Revenue		 0.00% 0.00% 365.81% 72.19% 121.53% 36.53% 31.73% 33.19% 22.75%
Net Working Capital to Revenue		 0.00% 0.00% 365.81% -93.10% 121.53% 36.53% 31.73% 33.19% 22.75%
Earnings Adjustments		 - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.27) ($1.92) ($3.19) ($4.83) ($0.94) ($1.33) ($1.08) ($0.81) ($0.80)
Adjusted Weighted Average Basic Shares Outstanding		 16.53M 27.27M 33.73M 43.73M 49.77M 56.07M 56.92M 62.02M 64.47M
Adjusted Diluted Earnings per Share		 ($0.27) ($1.92) ($3.19) ($4.83) ($0.94) ($1.33) ($1.08) ($0.81) ($0.80)
Adjusted Weighted Average Diluted Shares Outstanding		 16.53M 27.27M 33.73M 43.73M 49.77M 56.07M 56.92M 62.02M 64.47M
Adjusted Basic & Diluted Earnings per Share		 ($0.27) ($1.92) ($3.19) ($4.83) $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 16.53M 24.40M 28.24M 33.74M 55.69M 56.41M 57.94M 63.59M 65.06M
Normalized Net Operating Profit after Tax (NOPAT)		 -8.21 -32 -69 -47 -49 -42 -34 -24 -26
Normalized NOPAT Margin		 0.00% 0.00% -198.32% -82.57% -49.09% -28.06% -17.05% -9.05% -8.86%
Pre Tax Income Margin		 0.00% 0.00% -300.82% -288.18% -46.92% -50.01% -30.44% -18.69% -17.15%
Debt Service Ratios		 - - - - - - - - -
EBIT to Interest Expense		 -2,345.20 0.00 0.00 0.00 -18.78 -7.18 -3.51 -1.83 -1.69
NOPAT to Interest Expense		 -1,641.64 0.00 0.00 0.00 -13.15 -5.03 -2.49 -1.29 -1.16
EBIT Less CapEx to Interest Expense		 -2,345.20 0.00 0.00 0.00 -19.19 -7.51 -3.63 -2.09 -2.12
NOPAT Less CapEx to Interest Expense		 -1,641.64 0.00 0.00 0.00 -13.56 -5.35 -2.61 -1.54 -1.59
Payout Ratios		 - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 -28.71% -2.77% -0.23% 0.00% -0.46% 0.00% 0.00% -0.49% 0.00%

Quarterly Metrics And Ratios for Evolus

This table displays calculated financial ratios and metrics derived from Evolus' official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding		 - - - - - - 63,586,753.00 64,475,589.00 64,685,419.00 64,819,784.00 65,059,990.00
DEI Adjusted Shares Outstanding		 - - - - - - 63,586,753.00 64,475,589.00 64,685,419.00 64,819,784.00 65,059,990.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - - - - -0.30 -0.27 -0.24 0.00 -0.16
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 47.55% 39.76% 42.21% 35.59% 22.12% 29.42% 15.49% 3.70% 12.90% 14.38% 6.74%
EBITDA Growth		 29.54% 31.98% 32.08% 56.75% -16.81% 89.32% -84.41% -38.54% 31.53% 1,190.11% 71.68%
EBIT Growth		 25.28% 24.75% 26.50% 49.40% -13.27% 67.67% -70.27% -35.62% 21.35% 264.78% 55.49%
NOPAT Growth		 24.90% 18.82% 25.90% 49.05% -15.13% 73.20% -70.05% -32.56% 25.68% 165.76% 54.86%
Net Income Growth		 16.54% 10.13% 11.37% 37.43% -13.28% 42.60% -44.11% -51.03% 17.91% 101.91% 43.50%
EPS Growth		 16.67% 16.67% 15.38% 43.75% 0.00% 45.00% -36.36% -50.00% 20.00% 109.09% 46.67%
Operating Cash Flow Growth		 94.58% 109.27% 48.44% 51.39% -519.26% 491.39% -47.26% -283.17% -156.36% 166.78% 36.34%
Free Cash Flow Firm Growth		 71.07% 82.68% 96.52% 74.62% -42.96% 24.25% -1,794.58% -343.26% -149.06% -476.15% -123.46%
Invested Capital Growth		 4.75% 1.03% -11.38% 0.87% 13.56% 8.81% 12.32% 39.78% 74.73% 72.58% 64.54%
Revenue Q/Q Growth		 1.36% 21.95% -2.73% 12.77% -8.70% 29.24% -13.21% 1.26% -0.61% 30.93% -19.01%
EBITDA Q/Q Growth		 12.59% 47.32% -14.50% 17.96% -136.05% 95.18% -1,876.86% 38.37% -16.65% 176.70% -151.35%
EBIT Q/Q Growth		 11.13% 40.82% -11.79% 13.93% -98.95% 83.11% -488.82% 31.45% -15.38% 135.38% -259.05%
NOPAT Q/Q Growth		 11.10% 35.75% -3.32% 13.67% -100.90% 85.04% -555.66% 32.71% -12.63% 113.23% -550.00%
Net Income Q/Q Growth		 6.71% 30.09% -10.80% 13.42% -68.90% 64.57% -178.19% 9.26% 8.20% 100.83% -8,310.77%
EPS Q/Q Growth		 6.25% 33.33% -10.00% 18.18% -66.67% 63.33% -172.73% 10.00% 11.11% 104.17% -1,700.00%
Operating Cash Flow Q/Q Growth		 93.06% 187.99% -1,405.66% 39.05% 11.56% 184.03% -425.12% -58.59% 40.83% 187.44% -177.59%
Free Cash Flow Firm Q/Q Growth		 51.41% 42.10% 87.00% -594.08% -173.74% 69.32% -225.02% -62.39% -53.81% 29.03% -26.06%
Invested Capital Q/Q Growth		 -19.76% -0.56% 14.36% 10.54% -9.66% -4.72% 18.05% 37.57% 12.92% -5.90% 12.55%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 69.15% 63.57% 69.55% 71.49% 70.17% 63.77% 68.09% 65.31% 66.47% 65.66% 66.86%
EBITDA Margin		 -23.34% -10.08% -11.87% -8.64% -22.33% -0.83% -18.95% -11.54% -13.54% 7.93% -5.03%
Operating Margin		 -26.87% -14.16% -15.04% -11.51% -25.33% -2.93% -22.14% -14.71% -16.67% 4.67% -9.36%
EBIT Margin		 -26.83% -13.02% -14.96% -11.42% -24.88% -3.25% -22.06% -14.93% -17.33% 4.68% -9.20%
Profit (Net Income) Margin		 -33.83% -19.40% -22.09% -16.96% -31.38% -8.60% -27.57% -24.70% -22.82% 0.14% -14.59%
Tax Burden Percent		 100.14% 100.90% 100.36% 100.38% 100.70% 106.93% 100.38% 100.31% 101.07% 25.24% 102.46%
Interest Burden Percent		 125.93% 147.65% 147.14% 148.00% 125.24% 247.41% 124.51% 164.94% 130.24% 12.17% 154.85%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 74.76% 0.00%
Return on Invested Capital (ROIC)		 -95.98% -54.65% -51.59% -41.24% -111.32% -14.21% -95.48% -51.28% -57.74% 6.42% -31.61%
ROIC Less NNEP Spread (ROIC-NNEP)		 -120.01% -69.98% -72.95% -56.06% -129.34% -25.44% -116.80% -69.30% -68.85% 4.94% -38.94%
Return on Net Nonoperating Assets (RNNOA)		 -761.93% 2,411.86% -184.62% -364.83% 888.44% 154.44% -765.51% -11,617.44% 416.72% -35.65% 176.65%
Return on Equity (ROE)		 -857.92% 2,357.21% -236.21% -406.07% 777.12% 140.23% -860.99% -11,668.73% 358.98% -29.24% 145.04%
Cash Return on Invested Capital (CROIC)		 -103.72% -95.07% -59.94% -59.29% -84.79% -71.08% -75.26% -87.32% -101.89% -95.11% -76.02%
Operating Return on Assets (OROA)		 -27.48% -14.34% -17.01% -13.45% -31.08% -4.11% -27.65% -17.94% -22.09% 6.07% -12.79%
Return on Assets (ROA)		 -34.66% -21.36% -25.12% -19.99% -39.20% -10.87% -34.56% -29.69% -29.08% 0.19% -20.30%
Return on Common Equity (ROCE)		 -857.92% 2,357.21% -236.21% -406.07% 777.12% 140.23% -860.99% -11,668.73% 358.98% -29.24% 145.04%
Return on Equity Simple (ROE_SIMPLE)		 325.37% 0.00% -325.34% -275.52% -941.60% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 -9.41 -6.04 -6.25 -5.39 -11 -1.62 -11 -7.15 -8.05 1.07 -4.79
NOPAT Margin		 -18.81% -9.91% -10.53% -8.06% -17.73% -2.05% -15.50% -10.30% -11.67% 1.18% -6.55%
Net Nonoperating Expense Percent (NNEP)		 24.03% 15.33% 21.36% 14.83% 18.01% 11.23% 21.32% 18.01% 11.11% 1.47% 7.33%
Return On Investment Capital (ROIC_SIMPLE)		 - -6.06% - - - -1.28% -9.22% -5.64% -6.88% 0.87% -3.76%
Cost of Revenue to Revenue		 30.85% 36.44% 30.45% 28.51% 29.83% 36.23% 31.91% 34.69% 33.53% 34.34% 33.14%
SG&A Expenses to Revenue		 86.62% 70.59% 76.05% 74.96% 85.96% 63.64% 82.66% 81.68% 76.58% 60.53% 71.07%
R&D to Revenue		 3.17% 11.16% 3.50% 3.51% 3.79% 3.08% 3.23% 2.65% 2.97% 3.85% 3.06%
Operating Expenses to Revenue		 96.02% 77.72% 84.59% 83.00% 95.50% 66.70% 90.23% 80.03% 83.14% 60.99% 76.22%
Earnings before Interest and Taxes (EBIT)		 -13 -7.94 -8.88 -7.64 -15 -2.57 -15 -10 -12 4.23 -6.73
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -12 -6.15 -7.04 -5.78 -14 -0.66 -13 -8.01 -9.34 7.16 -3.68
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 0.00 0.00 43.98 35.17 173.54 126.60 0.00 0.00 0.00 0.00 0.00
Price to Tangible Book Value (P/TBV)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)		 2.82 2.98 3.69 2.86 4.12 2.63 2.78 2.14 1.39 1.45 0.89
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 15.58 17.90 19.82 15.18 25.16 18.31 17.31 10.41 6.80 7.57 4.80
Enterprise Value to Revenue (EV/Rev)		 3.12 3.26 3.80 2.98 4.26 2.76 2.97 2.44 1.75 1.76 1.24
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 -4.91 -5.82 6.54 6.26 20.58 22.00 -18.44 -7.80 -5.07 -6.32 -5.43
Long-Term Debt to Equity		 -4.91 -5.82 6.54 6.26 20.58 22.00 -18.44 -7.80 -5.07 -6.32 -5.43
Financial Leverage		 6.35 -34.46 2.53 6.51 -6.87 -6.07 6.55 167.65 -6.05 -7.21 -4.54
Leverage Ratio		 36.61 -167.57 15.22 32.61 -29.50 -27.80 37.13 698.75 -19.62 -26.07 -12.27
Compound Leverage Factor		 46.11 -247.42 22.39 48.26 -36.94 -68.77 46.23 1,152.50 -25.55 -3.17 -18.99
Debt to Total Capital		 125.58% 120.76% 86.74% 86.23% 95.37% 95.65% 105.73% 114.71% 124.58% 118.79% 122.55%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 125.58% 120.76% 86.74% 86.23% 95.37% 95.65% 105.73% 114.71% 124.58% 118.79% 122.55%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 -25.58% -20.76% 13.26% 13.77% 4.63% 4.35% -5.73% -14.71% -24.58% -18.79% -22.55%
Debt to EBITDA		 -2.14 -2.90 -3.16 -3.95 -3.72 -4.48 -3.68 -4.12 -4.70 -6.31 -11.29
Net Debt to EBITDA		 -1.27 -1.38 -0.62 -0.89 -1.11 -1.27 -1.63 -2.37 -3.30 -3.98 -7.69
Long-Term Debt to EBITDA		 -2.14 -2.90 -3.16 -3.95 -3.72 -4.48 -3.68 -4.12 -4.70 -6.31 -11.29
Debt to NOPAT		 -2.65 -3.49 -3.74 -4.46 -4.25 -5.04 -4.28 -4.81 -5.31 -6.39 -9.18
Net Debt to NOPAT		 -1.57 -1.67 -0.73 -1.01 -1.27 -1.43 -1.89 -2.77 -3.73 -4.04 -6.26
Long-Term Debt to NOPAT		 -2.65 -3.49 -3.74 -4.46 -4.25 -5.04 -4.28 -4.81 -5.31 -6.39 -9.18
Altman Z-Score		 -1.75 -1.08 0.19 -0.15 0.40 -0.26 -0.55 -1.02 -1.77 -1.32 -1.97
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 1.90 2.33 3.21 2.92 2.47 2.40 2.34 2.27 2.02 1.90 2.04
Quick Ratio		 1.42 1.93 2.80 2.53 2.13 2.14 2.05 1.72 1.41 1.44 1.50
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -11 -6.42 -0.83 -5.79 -16 -4.86 -16 -26 -39 -28 -35
Operating Cash Flow to CapEx		 -171.43% 225.21% -1,331.87% -515.95% -405.82% 353.01% -839.98% -1,093.56% -679.75% 592.20% -588.53%
Free Cash Flow to Firm to Interest Expense		 -2.93 -1.58 -0.18 -1.23 -3.33 -1.06 -3.58 -3.56 -9.64 -7.04 -8.89
Operating Cash Flow to Interest Expense		 -0.24 0.20 -2.26 -1.38 -1.20 1.05 -3.54 -3.44 -3.58 3.22 -2.50
Operating Cash Flow Less CapEx to Interest Expense		 -0.39 0.11 -2.43 -1.64 -1.50 0.75 -3.96 -3.75 -4.11 2.68 -2.93
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 1.02 1.10 1.14 1.18 1.25 1.26 1.25 1.20 1.27 1.30 1.39
Accounts Receivable Turnover		 7.19 7.63 7.62 6.58 6.61 6.81 6.74 6.12 6.01 5.81 6.06
Inventory Turnover		 2.84 4.32 3.86 4.32 4.59 7.25 8.07 4.58 3.99 5.12 5.88
Fixed Asset Turnover		 92.09 85.94 93.83 102.33 111.76 100.31 103.13 93.63 76.78 69.17 70.27
Accounts Payable Turnover		 5.48 9.77 6.31 7.93 5.83 12.43 6.35 5.43 5.18 6.14 5.74
Days Sales Outstanding (DSO)		 50.76 47.84 47.93 55.49 55.20 53.60 54.12 59.66 60.71 62.87 60.27
Days Inventory Outstanding (DIO)		 128.50 84.44 94.56 84.44 79.51 50.33 45.25 79.69 91.40 71.35 62.04
Days Payable Outstanding (DPO)		 66.64 37.36 57.88 46.02 62.59 29.36 57.46 67.20 70.41 59.45 63.61
Cash Conversion Cycle (CCC)		 112.63 94.93 84.61 93.91 72.12 74.58 41.92 72.15 81.70 74.77 58.70
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 37 37 42 47 42 40 47 65 73 69 78
Invested Capital Turnover		 5.10 5.51 4.90 5.12 6.28 6.92 6.16 4.98 4.95 5.44 4.82
Increase / (Decrease) in Invested Capital		 1.68 0.38 -5.41 0.40 5.02 3.24 5.19 19 31 29 31
Enterprise Value (EV)		 577 659 835 707 1,058 734 819 678 499 523 374
Market Capitalization		 521 602 811 679 1,022 699 765 594 397 431 267
Book Value per Share		 ($0.34) ($0.36) $0.32 $0.31 $0.09 $0.09 ($0.10) ($0.29) ($0.44) ($0.36) ($0.44)
Tangible Book Value per Share		 ($1.53) ($1.56) ($0.85) ($0.77) ($0.98) ($1.02) ($1.21) ($1.38) ($1.53) ($1.42) ($1.49)
Total Capital		 76 100 139 140 127 127 115 127 117 123 128
Total Debt		 95 120 121 121 121 122 122 145 146 146 156
Total Long-Term Debt		 95 120 121 121 121 122 122 145 146 146 156
Net Debt		 56 58 24 27 36 35 54 84 102 92 107
Capital Expenditures (CapEx)		 0.54 0.36 0.80 1.25 1.41 1.36 1.86 2.27 2.16 2.17 1.69
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 4.77 1.29 6.51 10 4.51 1.43 7.59 19 25 14 21
Debt-free Net Working Capital (DFNWC)		 43 64 103 104 90 88 75 81 68 68 71
Net Working Capital (NWC)		 43 64 103 104 90 88 75 81 68 68 71
Net Nonoperating Expense (NNE)		 7.52 5.79 6.86 5.96 8.34 5.17 8.27 10.00 7.69 0.94 5.88
Net Nonoperating Obligations (NNO)		 56 58 24 27 36 35 54 84 102 92 107
Total Depreciation and Amortization (D&A)		 1.74 1.79 1.83 1.86 1.56 1.91 2.13 2.36 2.62 2.93 3.05
Debt-free, Cash-free Net Working Capital to Revenue		 2.58% 0.64% 2.96% 4.36% 1.82% 0.54% 2.76% 7.01% 8.63% 4.64% 6.99%
Debt-free Net Working Capital to Revenue		 23.53% 31.73% 47.09% 43.84% 36.06% 33.19% 27.40% 29.22% 23.85% 22.75% 23.49%
Net Working Capital to Revenue		 23.53% 31.73% 47.09% 43.84% 36.06% 33.19% 27.40% 29.22% 23.85% 22.75% 23.49%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.30) ($0.20) ($0.22) ($0.18) ($0.30) ($0.11) ($0.30) ($0.27) ($0.24) $0.01 ($0.16)
Adjusted Weighted Average Basic Shares Outstanding		 57.02M 56.92M 58.80M 62.72M 63.15M 62.02M 63.70M 64.54M 64.73M 64.47M 65.19M
Adjusted Diluted Earnings per Share		 ($0.30) ($0.20) ($0.22) ($0.18) ($0.30) ($0.11) ($0.30) ($0.27) ($0.24) $0.01 ($0.16)
Adjusted Weighted Average Diluted Shares Outstanding		 57.02M 56.92M 58.80M 62.72M 63.15M 62.02M 63.70M 64.54M 64.73M 64.47M 65.19M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 57.15M 57.94M 62.61M 63.09M 63.32M 63.59M 64.48M 64.69M 64.82M 65.06M 65.85M
Normalized Net Operating Profit after Tax (NOPAT)		 -8.15 -6.04 -5.14 -4.27 -11 -1.62 -11 -7.15 -7.04 2.95 -4.79
Normalized NOPAT Margin		 -16.29% -9.91% -8.66% -6.38% -17.73% -2.05% -15.50% -10.30% -10.21% 3.27% -6.55%
Pre Tax Income Margin		 -33.79% -19.22% -22.01% -16.90% -31.16% -8.04% -27.47% -24.63% -22.58% 0.57% -14.24%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 -3.54 -1.95 -1.89 -1.63 -3.19 -0.56 -3.42 -1.44 -2.92 1.06 -1.69
NOPAT to Interest Expense		 -2.48 -1.48 -1.33 -1.15 -2.27 -0.35 -2.41 -0.99 -1.97 0.27 -1.21
EBIT Less CapEx to Interest Expense		 -3.69 -2.04 -2.06 -1.89 -3.49 -0.86 -3.85 -1.75 -3.45 0.52 -2.12
NOPAT Less CapEx to Interest Expense		 -2.63 -1.57 -1.50 -1.42 -2.57 -0.65 -2.83 -1.31 -2.49 -0.28 -1.63
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% -0.49% 0.00% 0.00% 0.00% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

Evolus (NASDAQ:EOLS) showed stronger sales momentum in Q1 2026, but profitability and cash flow remained under pressure. Revenue rose to $73.1 million from $68.9 million in Q3 2025 and $68.5 million in Q1 2025, suggesting the business is still growing. However, the company posted a net loss of $10.7 million in Q1 2026, and operating cash flow was negative $10.0 million. The balance sheet also shows a highly leveraged capital structure, with $156.4 million of long-term debt and negative common equity of $28.8 million.

  • Revenue improved year over year. Q1 2026 revenue of $73.1 million was up from $68.5 million in Q1 2025 and $68.9 million in Q3 2025, indicating continued top-line growth.
  • Gross profit remained strong. Q1 2026 gross profit was $48.9 million, representing a gross margin of about 66.9%, which is solid for a commercial-stage company.
  • Cash balance remains meaningful. Evolus ended Q1 2026 with $49.8 million in cash and equivalents, which provides some near-term liquidity.
  • Shares outstanding were relatively stable. Weighted average diluted shares in Q1 2026 were 65.2 million, not dramatically different from prior quarters, suggesting limited dilution recently.
  • Q4 2025 was a much better earnings quarter. The company generated net income of $0.1 million in Q4 2025 and positive operating cash flow of $12.8 million, showing that profitability can improve when operating leverage kicks in.
  • Depreciation and amortization continue to support reported earnings adjustments. Q1 2026 included $2.3 million of depreciation and $0.7 million of amortization, which helped partially offset the net loss in cash flow calculations.
  • Capital spending is modest. Q1 2026 capex was $1.7 million, while Q4 2025 capex was $2.2 million, so investment spending remains controlled.
  • Working capital is large, but not all of it is highly liquid. Current assets were $138.9 million, driven by $52.2 million in receivables and $24.8 million in inventory.
  • Q1 2026 returned to a loss after Q4 2025 breakeven profitability. Net income fell from a slight profit in Q4 2025 to a $10.7 million loss in Q1 2026.
  • Operating cash flow turned negative again. Q1 2026 operating cash flow was -$10.0 million, versus +$12.8 million in Q4 2025.
  • SG&A remained very heavy. Q1 2026 SG&A expense was $51.2 million, nearly as large as gross profit, limiting operating leverage.
  • Interest expense is a major burden. Q1 2026 interest expense was $4.0 million, and long-term debt stood at $156.4 million, keeping earnings under pressure.
  • The balance sheet shows negative equity. Total common equity was -$28.8 million at the end of Q1 2026, reflecting accumulated losses and a leveraged capital structure.
  • Cash declined in the quarter. Net change in cash and equivalents was -$4.0 million in Q1 2026, despite a $10 million debt issuance, indicating ongoing cash consumption.

Bottom line: Evolus is still growing revenue, but the company has not yet established consistent profitability or positive operating cash flow. The Q4 2025 rebound was encouraging, but Q1 2026 showed that expense pressure and interest costs can still quickly push results back into the red. For investors, the key question is whether revenue growth can outpace SG&A and debt-related costs over the next several quarters.

07/21/26 03:17 PM ETAI Generated. May Contain Errors.

Evolus Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Evolus' financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Over the last 8 years, Evolus' net income changed from -$4.48 million in 2017 to -$51.64 million in 2025, a change of 1,052.7%. View Evolus' forecast to see where analysts expect Evolus to go next.

Evolus' total operating income in 2025 was -$32.66 million, based on the following breakdown:
  • Total Gross Profit: $197.11 million
  • Total Operating Expenses: $229.77 million

Over the last 8 years, Evolus' total revenue changed from $0.00 in 2017 to $297.18 million in 2025, a change of 29,717,600,000.0%.

Evolus' total liabilities were at $248.97 million at the end of 2025, a 9.7% increase from 2024, and a 9.3% increase since 2017.

In the past 8 years, Evolus' cash and equivalents has ranged from $0.00 in 2017 to $146.26 million in 2021, and is currently $53.83 million as of their latest financial filing in 2025.

Over the last 8 years, Evolus' book value per share changed from -4.57 in 2017 to -0.36 in 2025, a change of -92.2%.


Related Companies

Financial statements for NASDAQ:EOLS last updated on 7/2/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
SPCX Warning - and Worst News for Stocks in 50 Years
Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...
TradeSmith | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
Elon’s new "tollbooth"
The SpaceX IPO was valued at $1.75 trillion. But one analyst says fighting over those shares may be the wrong ...
Weiss Ratings | Sponsoredtc pixel
Elon's new "super startup"
Adam O'Dell - the analyst who recommended Palantir before it became the top S&P 500 performer - has identified...
Banyan Hill Publishing | Sponsoredtc pixel